Nootropil (Piracetam)

Piracetam enhances neuronal membrane fluidity and modulates ion channels, which facilitates AMPA receptor activity and improves synaptic transmission. These actions increase neuroplasticity, cerebral blood flow, and metabolic efficiency, thereby supporting learning, memory formation, and overall cognitive performance.

The appropriate dose of Nootropil is determined by the prescribing clinician based on the individual’s medical condition, age, and response to therapy. Dosage regimens can vary, and patients should follow the specific instructions provided by their healthcare professional.

Safety data for piracetam in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used during pregnancy or breastfeeding if the potential benefits outweigh the potential risks, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will provide pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Piracetam is the prototypical racetam and is often compared with newer agents such as aniracetam or oxiracetam. While all share a similar mechanism of enhancing membrane fluidity, piracetam has the longest safety record and is widely used for cognitive support, whereas newer racetams may offer stronger potency but have less extensive clinical data.

Nootropil tablets should be stored at room temperature, below 25 °C, in their original packaging to protect them from moisture and light. Keeping the product in a dry, controlled environment helps maintain its stability and potency throughout its shelf life.

Nootropil is administered orally, typically as a tablet that is swallowed with water. The exact method of intake, including timing relative to meals, should follow the prescribing clinician’s guidance to ensure optimal absorption and therapeutic effect.

Serious but rare risks include severe allergic reactions such as skin rash, angioedema, or anaphylaxis, as well as hematologic abnormalities and, in extremely uncommon cases, seizures. Patients should seek immediate medical attention if they experience any signs of a severe reaction.

Individuals with known hypersensitivity to piracetam or any excipients in the tablet should avoid Nootropil. Additionally, patients with severe renal or hepatic impairment, pregnant or breastfeeding women without a clear medical indication, and those taking medications that may interact adversely should consult their healthcare provider before use.